Arango D - Search Results

1

Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.

Mouradov D, Sloggett C, Jorissen RN, Love CG, Li S, Burgess AW, Arango D, Strausberg RL, Buchanan D, Wormald S, O'Connor L, Wilding JL, Bicknell D, Tomlinson IP, Bodmer WF, Mariadason JM, Sieber OM. Mouradov D, et al. Among authors: arango d. Cancer Res. 2014 Jun 15;74(12):3238-47. doi: 10.1158/0008-5472.CAN-14-0013. Epub 2014 Apr 22. Cancer Res. 2014. PMID: 24755471

2

A gene expression profile that defines colon cell maturation in vitro.

Mariadason JM, Arango D, Corner GA, Arañes MJ, Hotchkiss KA, Yang W, Augenlicht LH. Mariadason JM, et al. Among authors: arango d. Cancer Res. 2002 Aug 15;62(16):4791-804. Cancer Res. 2002. PMID: 12183439

3

Short chain fatty acids and colon cancer.

Augenlicht LH, Mariadason JM, Wilson A, Arango D, Yang W, Heerdt BG, Velcich A. Augenlicht LH, et al. Among authors: arango d. J Nutr. 2002 Dec;132(12):3804S-3808S. doi: 10.1093/jn/132.12.3804S. J Nutr. 2002. PMID: 12468628

4

Microarray analysis in the clinical management of cancer.

Mariadason JM, Augenlicht LH, Arango D. Mariadason JM, et al. Among authors: arango d. Hematol Oncol Clin North Am. 2003 Apr;17(2):377-87. doi: 10.1016/s0889-8588(03)00006-6. Hematol Oncol Clin North Am. 2003. PMID: 12737394 Review.

5

Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression.

Klampfer L, Huang J, Corner G, Mariadason J, Arango D, Sasazuki T, Shirasawa S, Augenlicht L. Klampfer L, et al. Among authors: arango d. J Biol Chem. 2003 Nov 21;278(47):46278-87. doi: 10.1074/jbc.M304721200. Epub 2003 Sep 12. J Biol Chem. 2003. PMID: 12972432 Free article.

6

TR3/Nur77 in colon cancer cell apoptosis.

Wilson AJ, Arango D, Mariadason JM, Heerdt BG, Augenlicht LH. Wilson AJ, et al. Among authors: arango d. Cancer Res. 2003 Sep 1;63(17):5401-7. Cancer Res. 2003. PMID: 14500374

7

c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis.

Arango D, Mariadason JM, Wilson AJ, Yang W, Corner GA, Nicholas C, Aranes MJ, Augenlicht LH. Arango D, et al. Br J Cancer. 2003 Nov 3;89(9):1757-65. doi: 10.1038/sj.bjc.6601338. Br J Cancer. 2003. PMID: 14583781 Free PMC article.

8

Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.

Mariadason JM, Arango D, Shi Q, Wilson AJ, Corner GA, Nicholas C, Aranes MJ, Lesser M, Schwartz EL, Augenlicht LH. Mariadason JM, et al. Among authors: arango d. Cancer Res. 2003 Dec 15;63(24):8791-812. Cancer Res. 2003. PMID: 14695196

9

Customizing chemotherapy for colon cancer: the potential of gene expression profiling.

Mariadason JM, Arango D, Augenlicht LH. Mariadason JM, et al. Among authors: arango d. Drug Resist Updat. 2004 Jun;7(3):209-18. doi: 10.1016/j.drup.2004.05.001. Drug Resist Updat. 2004. PMID: 15296862 Review.

10

Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.

Arango D, Wilson AJ, Shi Q, Corner GA, Arañes MJ, Nicholas C, Lesser M, Mariadason JM, Augenlicht LH. Arango D, et al. Br J Cancer. 2004 Nov 29;91(11):1931-46. doi: 10.1038/sj.bjc.6602215. Br J Cancer. 2004. PMID: 15545975 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page